Bridgewater Associates LP Has $126,000 Position in Herbalife Ltd. (NYSE:HLF)

Bridgewater Associates LP lessened its stake in shares of Herbalife Ltd. (NYSE:HLF) by 71.5% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 18,806 shares of the company’s stock after selling 47,151 shares during the quarter. Bridgewater Associates LP’s holdings in Herbalife were worth $126,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Quadrant Capital Group LLC raised its holdings in Herbalife by 641.5% in the 4th quarter. Quadrant Capital Group LLC now owns 4,293 shares of the company’s stock valued at $29,000 after acquiring an additional 3,714 shares during the period. R Squared Ltd acquired a new position in shares of Herbalife in the fourth quarter valued at approximately $63,000. Van ECK Associates Corp lifted its holdings in Herbalife by 110.4% during the 4th quarter. Van ECK Associates Corp now owns 10,526 shares of the company’s stock worth $70,000 after purchasing an additional 5,524 shares during the last quarter. Headlands Technologies LLC lifted its holdings in Herbalife by 12,307.6% during the 4th quarter. Headlands Technologies LLC now owns 11,415 shares of the company’s stock worth $76,000 after purchasing an additional 11,323 shares during the last quarter. Finally, Range Financial Group LLC bought a new stake in Herbalife in the 4th quarter valued at $124,000.

Analyst Upgrades and Downgrades

Several research firms have weighed in on HLF. DA Davidson upgraded Herbalife from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $7.50 to $14.00 in a research report on Friday, March 21st. StockNews.com lowered shares of Herbalife from a “strong-buy” rating to a “buy” rating in a research report on Friday. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $12.00.

Herbalife Stock Performance

NYSE:HLF opened at $6.42 on Monday. The company has a market cap of $650.51 million, a price-to-earnings ratio of 2.58, a PEG ratio of 0.29 and a beta of 1.02. Herbalife Ltd. has a fifty-two week low of $5.04 and a fifty-two week high of $12.79. The stock has a fifty day moving average price of $7.68 and a 200-day moving average price of $7.26.

Herbalife (NYSE:HLF) last posted its quarterly earnings data on Wednesday, February 19th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.28. Herbalife had a net margin of 5.09% and a negative return on equity of 20.78%. The business had revenue of $1.21 billion during the quarter, compared to analysts’ expectations of $1.19 billion. Research analysts predict that Herbalife Ltd. will post 1.57 EPS for the current fiscal year.

Insider Buying and Selling

In other Herbalife news, Director Juan Miguel Mendoza acquired 5,000 shares of Herbalife stock in a transaction that occurred on Thursday, February 27th. The shares were acquired at an average cost of $8.25 per share, with a total value of $41,250.00. Following the completion of the purchase, the director now directly owns 132,500 shares of the company’s stock, valued at $1,093,125. This represents a 3.92 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.73% of the stock is currently owned by company insiders.

Herbalife Company Profile

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.